IL6 and prostate cancer: Expression of the atypical PKCλ or PKCι promotes hormone-independent growth of prostate cancer cells through the NF-κB dependent induction of pro-inflammatory proteins like IL-6, and genetic variants of PKCι have been associated with elevated prostate cancer risk [120,121].